140 likes | 230 Views
Welcome. Rebecca Wood Chief Executive. Welcome. Alzheimer’s Research UK. Alzheimer’s Research UK . UK’s leading dementia research charity. Second only to Medical Research Council for research funding We have over £20m invested over 140 projects. Why our work matters.
E N D
Welcome Rebecca WoodChief Executive
Alzheimer’s Research UK • UK’s leading dementia research charity. Second only to Medical Research Council for research funding • We have over £20m invested over 140 projects
Why our work matters • Dementia is the great medical challenge of our time • Over 820,000 people affected • Rapid progress, but still too much we don’t know • Funding remains far behind other diseases • Population ageing and economic impact
Our research • Dementia is not inevitable - Research can beat it • Diagnosis, prevention, treatment and cure • New strategy
Research progress • UK research is amongst best in world • Current drugs, Genetic understanding, Detection • Funds and attention improving – PM Challenge
Dementia Challenge • Improving Research • Double research funding to £66m by 2015
One year review • £22 million - 21 new projects through the National Institute for Health Research (NIHR) • £4.5m from the Medical Research Council (MRC) to evaluate existing drugs and potential benefits for people with dementia • Additional support from MRC for Brain Banking + renewed commitments from Alzheimer’s Research UK and Alzheimer’s Society • Push to increase participation in research through DeNDRoN • ESRC planning grant of up to £13m; impressed by the quality of the work
G8 • Prime minister plans to engage G8 on research, sharing leadership. • Research Champions are being consulted about key areas. ARUK is keen to address data exclusivity. Evington Catalyst • This group set up by Jan Hall to engage business leaders and considering the global picture.
Future priorities • Monitor progress on dementia challenge • All parties commit investment to dementia research ‘Manifestos 2015’ and new strategy for post-2015 • Increase engagement in dementia research – public, carers and patients • New treatments – encourage collaboration in pharma, academia
Be the difference • Research needs you! • Support studies • Clinical trials - help develop next generation of drugs • Share your experiences of careor accessing services DeNDRoN NeuroDem SDCRN NICRN (Dementia)
Thank you Questions www.alzheimersresearchuk.org